Diabetes in pregnancy

22
Diabetes in pregnancy Naghshineh.E MD

description

Diabetes in pregnancy. Naghshineh.E MD. GDM versus overt DM. do not have overt vasculopathy do not have increased risk of congenital malformations. Conditions more common in GDM:. Macrosomia Preeclampsia(daily low dose ASA) Hydramnios Stillbirth Neonatal morbidity (RDS) - PowerPoint PPT Presentation

Transcript of Diabetes in pregnancy

Page 1: Diabetes in pregnancy

Diabetes in pregnancy

Naghshineh.E MD

Page 2: Diabetes in pregnancy

diabetes in pregnancy 2

do not have overt vasculopathy do not have increased risk of congenital

malformations

GDM versus overt DM

Page 3: Diabetes in pregnancy

diabetes in pregnancy 3

Macrosomia Preeclampsia(daily low dose ASA) Hydramnios Stillbirth Neonatal morbidity (RDS)

Strict glycemic control:-exacerbation of diabetic retinopathy-may impair fetal growth-not teratogenic in humans

Conditions more common in GDM:

Page 4: Diabetes in pregnancy

diabetes in pregnancy 4

Glucose monitoring &control

Antenatal fetal testing(NST,BPP,CST):-GDM control with insulin or oral HGA:usually initiated at 32wks weekly, from 36 wks until delivery twice per week -GDM control with nutritional therapy :Not ante partum fetal surveillance

IUFD:3 per 1000 pregnancy (excluding congenital malformations)

Management of pregnancy

Page 5: Diabetes in pregnancy

diabetes in pregnancy 5

Assessment of fetal growth:-induction of labor-scheduled c/s-not optimal glycemic control

---EFW≥4800 gr → 50% chance FW≥4500 gr ---sono 28-32 wks, repeat 3-4 wks ,last 38 wkor---single sono at 36 wks---not recommended in GDM with nutritional

therapy

Management of pregnancy

Page 6: Diabetes in pregnancy

diabetes in pregnancy 6

PTL:16% Choice for tocolytic therapy : Nifedipin Or Indometacin Avoid Beta-adrenergic receptor : severe hyperglycemia Ante natal glucocorticoid : hyperglycemia 12 hrs after first dose, last 5 days

Management of pregnancy

Page 7: Diabetes in pregnancy

diabetes in pregnancy 7

-Benefits of induction: Avoidance of late stillbirth Avoidance of delivery-related complications

-Disadvantage of induction: c/s in failed induction tachysystole neonatal morbidity in<39 wks

Timing of delivery

Page 8: Diabetes in pregnancy

diabetes in pregnancy 8

GDM euglycemic with nutritional therapy: induction of labor at 40 wks GDM medically managed (ins or OHGA): induction of labor at 39 wks

ACOG recommended: c/s in DM :EFW≥4500 gr c/s in non DM: EFW≥5000 gr

Timing of delivery

Page 9: Diabetes in pregnancy

diabetes in pregnancy 9

Cervical ripening agents are safe Fallow labor progress closely

Operative vaginal delivery: only if fetal vertex has descended normally

Higher risk of shoulder dystocia & brachial plexus injury

Management of labor

Page 10: Diabetes in pregnancy

diabetes in pregnancy 10

avoid maternal hyperglycemia : risk of fetal acidosis & neonatal hypoglycemia

insulin requirement usually decrease during labor

Glucose is important for optimal myometrial function

GDM euglycemic with nutritional therapy: rarely require insulin during labor (2%) GDM medically managed (Ins or OHGA): may

need insulin infusion during labor (3.5%)

Labor & delivery

Page 11: Diabetes in pregnancy

diabetes in pregnancy 11

Poorly controlled DM: Diabetic fetopathy ( prolonged hypoglycemia secondary to pancreatic hyperplasia & hyperinsulinemia)

Maternal normoglycemia can not prevent neonatal hypoglycemia

Labor & delivery

Page 12: Diabetes in pregnancy

diabetes in pregnancy 12

Intrapartum glucose target:70-110 Check BS every 2-4 hrs during latent

phase ,1-2 hrs during active phase of labor Begin insulin infusion if BS>120 Check BS every 1 hour during insulin

infusion

GDM euglycemic with nutritional diet & exercise:

BS on admission, every 4-6 hours

Labor & delivery

Page 13: Diabetes in pregnancy

diabetes in pregnancy 13

Mild hyperglycemia is less morbid than hypoglycemia

BS<50, BS>180:treated promptly

Protocols: 1-N/S infusion, when BS<70: DW5% 2-DW5%(100-125 ml/h)+Ins(0.5-1u/h) 3-Rotating fluids(N/S,DW5%,LR)

Labor & delivery

Page 14: Diabetes in pregnancy

diabetes in pregnancy 14

Procedure scheduled early in morning NPO & Ins or OHGA withheld morning of

surgery Delay surgery until afternoon: 1/3 morning

NPH +DW5% (avoid ketosis) BS monitor & control with regular insulin

Hypoglycemia: wound infection, metabolic complications, neonatal hypoglycemia

Cesarian delivery

Page 15: Diabetes in pregnancy

diabetes in pregnancy 15

Check FBS,BS (2hpp): 24 h after NVD & 48h after c/s Relaxed BS level:140-160 during first24-48 h

If FBS<126: follow up If FBS>126: monitoring and therapy

Postpartum depression is more common follow up 6-8 wks later: GTT,75 gr,2 hr

GDM Postpartum management

Page 16: Diabetes in pregnancy

diabetes in pregnancy 16

DM-I: -1/2-2/3 (NPH+ Reg) prepartum

DM-II: -no medication first 24-48 hours -Ins 0.6 u/kg post partum weight -Metformin, glyburide (safe breastfeeding) -Metformin prefer in obese DM patients

Overt DM Postpartum management

Page 17: Diabetes in pregnancy

diabetes in pregnancy 17

Hb A1C<7% FBS<120 BS 2hpp<170

After hospital discharge

Page 18: Diabetes in pregnancy

diabetes in pregnancy 18

Insulin requirement:-early rise 3-7 wks-decline 7-15 wks-rise during reminder of pregnancy-if insulin fall after 35 wks>5-10%:R/O

placental insufficiency, fetal wellbeing tests ,not indication of delivery

Overt DM

Page 19: Diabetes in pregnancy

diabetes in pregnancy 19

Screening for aneuploidy:-first trimester & ultrasound markers not

affected by maternal DM-Second trimester (QT):Decreased AFP & uE3

,must be adjusted MSAFP:NTD(2%) Anomaly scan:18 wks Fetal echocardiogram ? (50% ,conotruncal &VSD)

Overt DM

Page 20: Diabetes in pregnancy

diabetes in pregnancy 20

Timing for delivery:- Well controled:38+4 wks- With vascular disease:37 wks

Overt DM

Page 21: Diabetes in pregnancy

diabetes in pregnancy 21

Any type is acceptable Progestin-only pills, DMPA, levonogestrol

IUD : increased risk of developing DM-II ? Copper IUD

Contraception

Page 22: Diabetes in pregnancy

diabetes in pregnancy 22

Towards a safe motherhood